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Abstract Atherosclerosis has many features of a chronic
inflammatory disease. To evaluate the role of lipopolysaccharide
(LPS), mimicking a systemic infection, we administered the
endotoxin to apolipoprotein E (apoE)-deficient mice. LPS
injections increase the atherosclerotic lesion size and the titer
of plasma autoantibodies directed against oxidized low-density
lipoprotein. We found that Th1 and Th2 T cells help the
activation of B cells in the autoimmune response. The number of
interleukin-4 producing natural killer T cells is highly increased
in peripheral blood, liver, spleen and thymus cells, as well as in
the atherosclerotic plaque of the LPS-treated mice. Finally, an
important adventitial infiltrate of activated lymphocytes, sign of
an advanced atherosclerosis, is observed only in the LPS-treated
mice. Our results demonstrate that LPS administration aggra-
vates atherosclerosis in apoE-deficient mice. LPS-injected apoE-
deficient mice appear to be an excellent animal model to analyze
the implementation of new therapeutic approaches in the
treatment of atherosclerosis by manipulating immunological
effectors. - 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Atherosclerosis has many features of a chronic in£amma-
tory disease, in which both cell-mediated and humoral im-
mune responses participate. Recent evidence suggests that
common bacteria and viruses can contribute to the develop-
ment of atherosclerosis, probably by triggering in£ammation.
Thus, epidemiological studies have shown the presence of
Chlamydia pneumoniae and cytomegalovirus in the plasma
or even in the atherosclerotic plaque from heart disease pa-
tients [1^3]. An increased incidence of coronary artery disease
also occurs in patients with Helicobacter pylori infections,
chronical dental infections, and chronic bronchitis, infections
in which microorganisms are not localized in the vessel wall
[4^6]. However, it is still uncertain whether or not microor-
ganisms play a causal role in atherosclerosis and its compli-
cations.
Chronic infection can be mimicked by infusion of endotox-
ins, for example lipopolysaccharide (LPS) component of the
Gram-negative bacteria cell wall. This bacterial endotoxin,
carried by lipoproteins, may cause a local in£ammation after
incorporation of the lipoproteins into the vascular wall. Re-
cently, it has also been suggested that increased low-density
lipoprotein (LDL) oxidation could be one of the mechanisms
by which infection and in£ammation may promote athero-
genesis, reactive oxygen being generated as part of the host
defense [7]. In this way, C. pneumoniae was recently found to
induce cellular oxidation of LDL [8].
The development of murine models permits a dissection of
immune mechanisms in atherosclerosis. Genetic variation at
the apolipoprotein E (apoE) locus in human is associated with
hyperlipidemia and premature atherosclerotic risk. Mice with
a targeted disruption of the apoE (apoE0 or apoE-de¢cient
mice) develop severe atherosclerosis that progresses from fatty
streaks to ¢brofatty plaques and advanced lesions. These mice
are considered as an animal model for the study of factors
involved in atherogenesis such as oxidation and in£ammation.
In these animals, studies using antisera speci¢c for malondial-
dehyde (MAD)-lysine and 4-hydroxynonenal-lysine have re-
vealed the existence of oxidation-speci¢c epitopes in athero-
sclerotic lesions and have detected important levels of
autoantibodies directed against MAD-lysine in their plasma
[9]. Immunohistochemical analysis of aortic lesion of these
mice revealed a prominent involvement of macrophages and
T lymphocytes. Some of these T cells express surface mole-
cules as the interleukin (IL)-2 receptor K-chain (CD25), indi-
cative of recent activation [10]. Interestingly, it was reported
that Th1 cells secreting interferon (IFN)-Q are found early in
fatty streak lesions, but are replaced in severe hypercholester-
olemia induced by cholesterol feeding by Th2 cells and their
associated cytokines, IL-4 and IL-1 [11]. These data indicated
that a high-cholesterol diet may in£uence T cell participation
in atherosclerosis. In addition, it has recently been demon-
strated that apoE0 mice are more susceptible than wild-type
C57Bl/6 mice to endotoxemia. This is probably due to the
absence of apoE, since this apolipoprotein was demonstrated
to be involved in the detoxi¢cation of LPS [12,13]. In con-
trast, LDL receptor-de¢cient mice are protected against endo-
toxemia compared with wild-type mice. Thus, apoE0 mice
seem to be a model of special interest to study the role of
LPS in atherogenesis.
In this report we evaluate the role of LPS, mimicking a
systemic infection, on the development of atherosclerosis.
This was done by exploring humoral and cellular immune
responses. We have administered LPS to apoE-de¢cient
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mice, and we have analyzed the atherosclerotic surface lesion,
the concentration of autoantibodies directed against oxidized
LDL (oxLDL) in plasma, the ex vivo cytokine production by
lymphocyte subsets in blood, liver, spleen and thymus, and
the expression of cytokine and lymphocyte markers in the
atherosclerotic plaque.
2. Materials and methods
2.1. Experimental animals
Male apoE-de¢cient mice bred into a C57Bl/6 background were
obtained from Jackson Laboratory. Mice were housed in a temper-
ature-controlled room with an alternating light and dark period. They
were fed a mouse chow diet (UAR, France) and had access to water
ad libitum.
At 10 weeks of age, male apoE0 mice were randomly divided into
three groups (n=4 per group). The ¢rst one was injected intraperito-
neally with LPS (50 Wg) once every week during 10 weeks (LPS
group), the second group was injected with LPS only once (LPS1
group) and the last group was injected with an equivalent volume
of phosphate-bu¡ered saline (PBS) once every week during 10 weeks
(PBS group). In order to analyze the basal immunological response in
wild-type C57Bl/6 animals, we constituted two groups (n=5 per
group), the ¢rst one was injected with LPS and the second one was
injected with PBS. Animals were bled 24 h after each treatment. For
blood collection, food was removed from the cages at 9 a.m., and 8 h
later, samples were collected from the retro-orbital sinus under iso-
£uorane anesthesia. At the end of the study animals were killed by
exsanguinations via cardiac puncture, perfused transcardially with
PBS and the heart, liver, spleen and thymus were excised. All proce-
dures involving animal handling and their care were in accordance
with the Institut Pasteur Guidelines for Husbandry of Laboratory
Mice.
2.2. Plasma lipid quanti¢cation
The plasma concentration of cholesterol and triglycerides was de-
termined enzymatically using commercial kits (Boehringer Mannheim,
Germany).
2.3. Evaluation of aortic lesions
Because the correlation is strong between the extent of atheroscle-
rosis in the aortic root and the entire aortic tree in murine atheroscle-
rosis models [14], we measured lesions in the aortic root by use of the
method described by Paigen et al. [15]. In brief, hearts and proximal
aortas were removed and ¢xed. Hearts were cut directly under and
parallel to the lea£et, and the upper portions were embedded in OCT
medium and frozen. 10-Wm-thick sections were cut through the aortic
sinus. Twenty-eight sections per animal were stained for lipids with
Oil-red O and counter-stained with hematoxylin. Cross-sectional areas
were analyzed by computerized planimetry. Statistical analysis was
performed on ¢ve di¡erent cross-sectional lesion areas per animal,
separated by 120 Wm. The ¢rst section analyzed for each animal cor-
responded to the origin of the aortic sinus. The intermediate sections
were used to perform immunohistochemistry assays.
2.4. Determination of anti-oxLDL antibodies
Human LDL was isolated as described [16]. OxLDL was prepared
by incubating LDL (1 mg/ml) with 5 Wmol/l CuSO4 in PBS overnight
at 37‡C. Before each assay, 96-well microtitration plates were freshly
coated with 100 Wl of oxLDL (5 Wg/ml) in PBS overnight at 4‡C. The
wells were blocked with 1% bovine serum albumin for 2 h at room
temperature. A 100 Wl aliquot of diluted sera (1:40) from each group
of mice was added in duplicated wells and incubated for 2 h at room
temperature. After three washes with PBS containing 0.1% Tween-20,
goat anti-mouse IgM, IgG1, IgG2a, IgG2b, IgG3 and IgA conjugated
with alkaline phosphatase (1:1000 dilution, Beckman-Coulter, Paris,
France) were added to each well, and incubation continued for 2 h at
room temperature. Plates were washed again, and the alkaline phos-
phatase activity was determined using p-nitrophenyl phosphate as a
substrate and detected at 405 nm.
2.5. Cell preparation
Peripheral blood, spleen and thymic cells from each animal, killed
as described above, were isolated by density centrifugation, washed
three times in PBS. Hepatic lymphocytes were isolated by a method
described elsewhere [17]. The liver was removed and cut in two pieces,
one half was passed through 200-gauge steel mesh, and then sus-
pended in RPMI medium with 5% of heat-inactivated calf serum.
Once the cells washed, the lymphocytes were isolated by a gradient
of Percoll (35% Percoll containing 100 U/ml heparin, Sigma, St.
Louis, MO, USA). Puri¢ed lymphocytes were washed three times
before culture.
2.6. Flow cytometric cytokine detection assays
Puri¢ed cells were incubated overnight at 37‡C with 5% CO2 in
brefeldin A (2 Wg/ml, Sigma, St. Louis, MO, USA). Cells were recov-
ered and incubated for 30 min at 25‡C with either FITC-, PE-, Cy-
Chrome-, or PerCP-conjugated monoclonal antibodies directed
against CD4, CD8, CD3 and NK1.1 (Pharmingen, Boston, MA,
USA). At the end of incubation, the cells were washed two times in
PBS and ¢xed with 200 Wl of 2% formaldehyde solution for 15 min at
25‡C. The cells were washed two more times and 150 Wl of permeabi-
lization solution (0.005% of saponin, Sigma, St. Louis, MO, USA), in
PBS solution with 5% of fetal calf serum, for 10 min. After incuba-
tion, cells were centrifuged for 5 min and the supernatants discarded.
2.5 Wl of anti-cytokines monoclonal antibodies (anti-IFN-Q, tumor
necrosis factor (TNF)-K, and IL-4, Pharmingen, Boston, MA, USA)
diluted in permeabilization bu¡er were added for 30 min at 20‡C.
Cells were washed twice in PBS and 500 Wl of PBS was added before
analysis. Positive controls for cytokine production were cells from
injected and non-injected animals stimulated with PMA/ionomycin
(10/500 ng/ml, Sigma, St. Louis, MO, USA), and incubated with bre-
feldin 2 Wg/ml (Sigma, St. Louis, MO, USA) overnight. Negative
controls were incubated with irrelevant, isotype-matched antibodies
in all experiments and with a background £uorescence not higher
than 0.03%. Cell events were acquired by using gates set by forward
and side scatter to determine the di¡erent proportions of positive
cells. At least, 25 000 live lymphocytes were analyzed in order to
determine the proportions of populations.
2.7. Immunohistochemistry
Immunohistochemistry was performed in aortic sinus sections. Tis-
sue sections were pretreated with acetone and incubated with 2% gel-
atin in PBS at 37‡C for 45 min in a humidi¢ed chamber. After wash-
ing with 0.1% Triton X-100 in PBS, sections were incubated with the
appropriate antibody for 1 h and then washed three times. All anti-
bodies were used at optimal dilutions determined by staining of spleen
sections. The following monoclonal antibodies were used to detect the
presence of TNF-K (anti-TNF-K, BD Pharmingen, 1:50), natural kill-
er or natural killer T cells (NK and NK-T cells, anti-NK1.1, BD
Pharmingen, 1:30), activated lymphocytes T, B and NK cells (anti-
CD69, BD Pharmingen, 1:30), IgM (anti-mouse IgM, Sigma, 1:200)
and IgG (anti-mouse IgG, Sigma, 1:800). Controls were performed
with an irrelevant isotype-matched monoclonal antibody.
2.8. Statistical analysis
Data were expressed as meanRS.D. Statistical analyses were per-
formed using the analysis of variance (ANOVA) test. Di¡erences were
considered signi¢cant at P6 0.05. All analyzed variables except tri-
glycerides were normally distributed as assessed by the Kolmogorov^
Smirnov test. Triglyceride values were logarithmically transformed to
achieve an approximately normal distribution, and ANOVA was then
applied to the transformed values.
3. Results
This study was designed to evaluate atherosclerotic lesion
size and in£ammatory responses in apoE0 mice after LPS
administration.
3.1. E¡ect of LPS injection on atherosclerotic lesion size and
lipid metabolism
At 20 weeks of age, apoE0 mice develop ¢brofatty plaques
with lipid-rich core regions covered by ¢brous caps. Mice
treated several times with LPS (LPS group) showed a 83%
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increase in lesion size, compared with the PBS-treated con-
trols (PBS group) (219 100R 22 600 Wm2 versus 120 300R
22 600 Wm2 ; P6 0.02). Mice treated once with LPS (LPS1
group) showed also an increase in the lesion size but it was
not statistically signi¢cant when compared with control mice
(174 900R73 100 Wm2 versus 120 300R 22 600 Wm2). The re-
sults obtained indicate that LPS injections promote athero-
genesis. Triglyceride and cholesterol concentrations in plasma
were signi¢cantly reduced in the LPS group compared with
the PBS group. In contrast, no di¡erences were observed be-
tween the LPS1 and the PBS groups (Table 1).
3.2. Detection of autoantibody response to oxLDL in LPS and
in control PBS mice
The titer of autoantibodies directed against oxLDL was
found to be signi¢cantly increased in the sera of LPS mice
compared with that of the PBS counterpart (Fig. 1). In addi-
tion, the animals from the LPS1 group also presented a sig-
ni¢cant, although lower increase in the plasma concentration
of anti-oxLDL antibodies (data not shown). We also found
that the LPS mice have developed major titers of IgM, of the
di¡erent isotypes of IgG and of IgA antibodies to oxLDL,
than the PBS group (Fig. 1). These results suggest either a role
for T cell help during the activation of the B cells in the
autoimmune response against oxLDL, or a polyclonal activa-
tion of B cells induced by LPS.
3.3. Ex vivo detection of cytokines produced by lymphocyte
subsets in blood, liver, spleen and thymus
The autoimmune response to oxLDL detected in the LPS-
and PBS-treated apoE0 mice prompted us to analyze the lym-
phocyte subsets that could mediate this response. To identify
the distribution of the di¡erent subsets, three color stainings
were conducted ¢rst in peripheral blood cells, with the follow-
Table 1
Plasma lipid concentration in LPS-, LPS1- and PBS-treated apoE0
mice
Cholesterol (mg/dl) Triglycerides (mg/dl)
LPS 319R12* 89R 102
LPS1 403R52 143R 46
PBS 396R53 396R 53
Values are meanRS.D. *P6 0.05, 2P6 0.02 LPS- vs. PBS-treated
mice.
Fig. 1. E¡ect of LPS injections on plasma levels of autoantibodies
directed against oxLDL. Total Ig and Ig isotypes were analyzed by
enzyme-linked immunosorbent assay. OD indicates optical density.
Data are expressed as meanRS.D. ***P6 0.0003; **P6 0.008;
*P6 0.05 LPS- vs. PBS-treated apoE0 mice.
Fig. 2. Cytometric analysis of cytokines producing T cells in blood.
Lymphocyte subsets of LPS-, LPS1- or PBS-treated apoE0 mice
were obtained as indicated in Section 2. Results are expressed as
percentage of IL-4 positive cells among CD3þNK.1.1þ (A), of IFN-
Q positive cells among CD3þCD4þ (B) and of TNF-K positive cells
among CD3þCD8þ (C). 1, 2, 3 and 4 correspond to samples ob-
tained 24 h after each injection in LPS- and PBS-treated mice. The
LPS1 group of animals was injected once at the onset of the experi-
ments. Data are expressed as meanRS.D. ***P6 0.005; **P6 0.01;
*P6 0.05 LPS- vs. PBS-treated mice. 33P6 0.01; 3P6 0.02 LPS1-
vs. PBS-treated mice.
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ing combinations: CD3/NK1.1/IL-4, CD3/CD4/IFN-Q and
CD3/CD8/TNF-K. The proportion of lymphocyte subsets
was (mean, range): CD4 35.2% (27^43), and CD8 23% (16^
25.5), and concerning NK1.1 were 5.7% (2.9^8.1) in apoE0
LPS-injected mice and 3.3% (0.9^3.3) in apoE0 control mice.
In wild-type C57Bl/6 LPS-injected or not, the proportions of
lymphocyte subsets were not di¡erent from those obtained in
control apoE-de¢cient mice. The results of cytokine produc-
tion are shown in Fig. 2. In general, apoE0 LPS mice showed
an increase of cytokine producing cells, when compared with
the PBS-injected apoE0 (Fig. 2) or with the C57Bl/6 wild-type
LPS-injected mice (data not shown). In particular, the pro-
portion of IL-4 producing cells highly increased over the time
after several injections of LPS (Fig. 2A). This was also ob-
served in LPS1 and PBS^apoE0 mice, but in a signi¢cant low-
er proportion (Fig. 2A). Interestingly, the vast majority of IL-
4 producing cells in LPS animals were CD3þNK1.1þ cells. In
contrast, the number of CD3þNK1.1þ cells producing IFN-Q
was similar in the LPS and the PBS groups. An increase of
other IFN-Q producing cells was observed in the LPS mice,
compared with control mice (Fig. 2B). A similar increase was
also detected in TNF-K producing cells (Fig. 2C). The pheno-
typing of these IFN-Q and TNF-K producing cells was
CD3þCD4þIFN-Qþ (Fig. 2B), CD3þCD8þTNF-Kþ (Fig. 2C)
and CD3þCD8þIFN-Qþ (data not shown). Finally, IL-6 and
IL-10 producing cells were not detected.
We also analyzed the frequency of cytokine positive cells in
liver, thymus and spleen, organs in which lymphocytes nor-
mally develop. In all cases, a higher increase in cytokine
producing resident cells was observed in LPS mice compared
with control animals (PBS group and LPS C57Bl/6 mice).
As in blood, the most prominent increase was detected in
the CD3þNK1.1þ cells producing IL-4 (Fig. 3A). IFN-Q and
TNF-K were also detected in all the tissues tested, and the
phenotyping of their producing cells was CD3þCD4þ
(Fig. 3B) and CD3þCD8þ (data not shown), as observed in
blood.
All these results pointed out the enhanced production of
pro-in£ammatory cytokines and the T cell-dependent response
following LPS injection in atherosclerosis-prone apoE0 mice.
3.4. Lymphocyte-dependent cytokine production in
atherosclerotic lesions
Immunohistochemical studies showed that LPS mice pre-
sented a higher number of NK1.1 cells and an enhanced IL-
4 production in atherosclerotic lesion in LPS mice, compared
with lesion in PBS mice. Both antibodies co-localized, indicat-
ing that NK1.1 cells were the principal cellular type implicated
in the IL-4 plaque production (Fig. 4A^C). In contrast, CD4þ
cells producing IFN-Q were more abundant in plaques from
PBS-treated mice, than in those of LPS mice (data not
shown). Few NK-T cells (less than 5%) in both PBS- and
LPS-treated mice were stained with IFN-Q monoclonal anti-
body (data not shown). Finally, lymphocytes producing
TNF-K were more abundant in LPS mice (Fig. 4D).
The expression of CD69, a lymphocyte marker of recent
activation, was analyzed in aortic sinus sections of LPS-
treated mice and of PBS-treated control mice. We found
that atheroma from LPS animals presented an accumulation
of activated lymphocytes in the intima (Fig. 5A) that was not
present in control mice. Nevertheless, we cannot rule out that
the NK-T cells express constitutively the CD69 marker, as in
liver. Interestingly, adventitia from treated mice showed also
an important in¢ltration of CD69 expressing cells (Fig. 5A).
Furthermore, LPS-treated mice showed in both intima and
adventitia a high concentration of IgG and IgM (Fig. 5B,C).
In adventitia, the disposition of these immunoglobulins was in
aggregates resembling lymphoid follicular structures, which
have been associated with advanced atherosclerotic plaques,
evoking a late humoral immune response. These results are
consistent with the fact that LPS animals presented more
advanced atherosclerotic lesions. Even if the immunogens
are unknown, they could be related to the high titers of auto-
antibodies directed against oxLDL detected in the plasma of
treated mice.
4. Discussion
Atherosclerosis is a progressive disease considered as a form
of chronic in£ammation, resulting from the interaction be-
tween modi¢ed lipoproteins, mainly oxLDL, monocytes/mac-
Fig. 3. Cytometric analysis of cytokine producing T cells in liver,
spleen and thymus. At the end of the experiments, the organs were
dissected and T cells puri¢ed. Results are expressed as percentage of
IL-4 positive cells among CD3þNK1.1þ (A), and of IFN-Q positive
cells among CD3þCD4þ (B). Data are expressed as meanRS.D.
***P6 0.001; **P6 0.01 LPS- vs. PBS-treated mice. 333P6 0.001;
33P6 0.01 LPS1- vs. PBS-treated mice.
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rophages and T cells with the components of the arterial wall.
In the present report, we analyze the relationship between a
chronic infection triggering in£ammation, mimicked by LPS
injection, and the development of atherosclerosis in apoE0
mice. We have observed that repeated injections of LPS in-
crease atherosclerotic lesion size, strongly suggesting that the
activation of innate immunological system promotes athero-
genesis.
The increased atherogenesis was observed in spite of a
reduction in triglyceride and cholesterol plasma concentra-
tion. We do not known the reason of this reduction; but
we can exclude that it was caused by liver toxicity, since the
LPS dose used has been reported to be low hepatotoxic [18].
Recently, in experiments with rabbits submitted to repeated
injections of LPS, a tendency in the reduction of these plas-
ma parameters was also observed, but the high dispersion of
the data did not allow the obtaining of statistically signi¢-
cant values [19].
It is well known that oxidative modi¢cations in the lipid
and apolipoprotein B components of LDL promote the for-
mation of fatty streaks. In accordance, apoE0 mice injected
with LPS presented in plasma a higher titer of antibodies
directed against oxLDL than the control counterparts. ApoE0
LPS mice, but also PBS-treated mice developed IgM, IgG and
IgA anti-oxLDL antibodies. This is compatible with a role of
T cell help during the activation of the B cell response. Th1-
Fig. 4. Immunochemical study of atherosclerotic lesions in LPS- and PBS-treated apoE0 mice. Heart sections were analyzed with antibodies di-
rected against: NK1.1 (A), IL-4 (B), double staining NK1.1/IL-4 (C) and TNF-K (D). Original magni¢cation U400.
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type cells stimulate B cells to synthesize IgG2a isotype where-
as Th2-type T cells stimulate production of IgG1 antibodies
[20]. As the concentrations of these two IgG subclasses of
antibodies directed against oxLDL were enhanced in the plas-
ma of LPS-injected mice, we can consider that, instead of a
polyclonal activation of B cells, the two Th1- and Th2-type T
cells are indeed involved in the antibody response against
oxLDL. However, we cannot exclude that the increase in
the levels of autoantibodies to oxLDL observed in LPS-in-
jected apoE0 mice could be partially explained by LPS-in-
duced polyclonal B cell activation.
Th1 cells secrete the proatherogenic IFN-Q, Th2 cells pro-
vide help by secretion of IL-4 and both Th1 and Th2 cells
secrete TNF-K [20]. To go deeper into the analysis of the
lymphocyte subsets mediating the autoimmune response to
oxLDL in LPS and control mice, we studied these subsets
in cells of peripheral blood, liver, spleen and thymus of these
animals. In each case, £ow cytometric cytokine detection as-
says showed principally an increase of the IL-4 producing cells
in LPS mice. The phenotyping of these cells indicated that the
majority were NK-T cells, expressing the NK1.1 marker.
NK-T cells are a well characterized subset of T cells in terms
of morphology, phenotype, tissue distribution and cytokine
production [21]. Several studies suggested a role for NK-T
cells in the regulation of autoimmune diseases [22^25]. In
our experimental conditions, the increase of IL-4 secreting
NK-T cells could be correlated with an increase in the levels
of autoantibodies against oxLDL. These results raise the pos-
sibility that NK-T cells themselves could become e¡ector cells
in the autoimmune manifestations of atherosclerosis, contrib-
uting to the tissue destruction mediated by T and B cells. In
addition to the NK-T cells activity, the increase of CD4 and
CD8 T cells secreting IFN-Q and TNF-K in LPS mice, when
compared with control mice, con¢rms that both cell popula-
tions are also implicated in the pro-in£ammatory process ob-
served in the present atherosclerotic model.
In contrast to these results, we did not observe an immuno-
logical response in the wild-type C57Bl/6 mice after their
Fig. 5. Immunochemical study of intima and adventitia of atherosclerotic lesions in LPS-treated apoE0 mice. Sections were analyzed with anti-
bodies directed against CD69 (A), mouse IgG (B) and mouse IgM (C). Arrow indicates a breach in the media, binding the atherosclerotic com-
ponents in contact with the adventitia. Original magni¢cation U400.
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treatment with LPS. Thus, hypercholesterolemia, a property
of apoE0 mice, could modulate the immunological response to
LPS. Similarly to our results, the repeated injections of LPS in
hypercholesterolemic rabbits increased the monocytes percent-
age in blood and increased atherosclerotic lesions. However,
normolipidemic rabbits did not develop atherosclerotic lesions
and did not present an increase in monocyte percentage after
LPS injection [19]. This suggests that the immunopathological
consequences of an in£ammation in the atherosclerotic pro-
cess would become apparent when the cholesterol transport
system is overloaded.
Our immunochemical studies indicated that the atheroscle-
rotic plaques of the LPS mice are in¢ltrated mainly by NK1.1
cells secreting IL-4, a Th2 activity, and also T cells secreting
TNF-K were observed principally in the plaques of LPS-
treated mice. In contrast, no Th1 cells were detected in the
LPS lesion, since CD4 cells secreting IFN-Q were mainly ob-
served in the atherosclerotic lesion of the control apoE0 mice.
The detection of the early lymphocyte activation marker
CD69 in the plaques suggests that the NK-T cells activity
participates in the onset of immune dysfunction contributing
to the atherosclerotic disease. Interestingly, Yamazaki et al.
have recently described an elevated proportion of NK-T cells
in chronic in£ammatory periodontal disease tissues, which is
caused by a group of Gram-negative bacteria [26]. They have
postulated that NK-T cells were recruited to regulate an auto-
immune response and that they may control cellular and hu-
moral immune responses. However, NK-T cells are not a
homogenous population and two major subsets have been
described: CD4þ and CD43 populations. These two subsets
have di¡erent functional activities that may account for the
role of these cells in atherosclerosis. CD4þ subset has a pro-
tective role in autoimmune disease but CD43 NK-T cells play
a pathogenic role by mediating cytotoxic activity in response
to in£ammatory stimulus. These di¡erent activities are medi-
ated by unknown immunoregulatory mechanisms.
We have also found an important adventitial in¢ltrate of
activated lymphocytes in LPS-treated mice. This was not ob-
served in control mice. This phenomenon, named periaortitis,
is produced when thinning or breaching of the media. As
shown with the CD69 staining in the intima, the media is
breaching in the LPS lesion, bringing the atherosclerotic com-
ponents in contact with the adventitia. This in¢ltrate was
described to be associated with advanced atherosclerotic
plaques [27,28], and their structural organization is related
to a late humoral immune response. This result is consistent
with the fact that treated mice have twice as many autoanti-
bodies against oxLDL. Interestingly, a greater level of anti-
oxLDL has been found in patients with coronary atheroscle-
rosis compared with that in healthy individuals [29]. Thus, a
chronic infection mimicked by LPS injections provokes a
more severe atherosclerosis in apoE0 mice. This is accompa-
nied by an increase in the titer of autoantibodies directed
against oxLDL. Our results also underline the importance
of NK-T cells and their cytokine secretion in the autoimmune
manifestations of atherosclerosis.
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